Por: MarketWatch Business November 10, 2023
Shares of (TTD) tumbled 17% after the internet advertising platform company’s missed analysts’ expectations. Trade Desk said it , below estimates of $610 million. It also forecast adjusted earnings before interest, taxes, depreciation, and amortization of approximately $270 million, below Wall Street estimates of $291 million. (DOCS), the online platform for medical professionals, and said its board authorized the repurchase of up to $70... + full article
ABC News USA Business July 12, 2023
BRUSSELS -- The European Union on Wednesday slapped a $475 million fine on U.S. biotech giant Illumina for buying out cancer-screening company Grail without the approval of the 27-nation bloc's antitrust watchdog, the latest setback for the deal.Illumina announced an $7.1... + más
Biotech company Illumina pushes back against Carl Icahn’s proxy fight over $7.1 billion Grail deal | CNBC
FTC orders Illumina to unwind $7B deal for cancer test developer Grail | Fox Business
ABC News USA Health July 12, 2023
ABC News USA Tech July 12, 2023
MarketWatch USA Business May 25, 2023
Illumina is holding its annual meeting at 1 p.m. Eastern time, at which the results of the proxy vote will be announced. The meeting will be held virtually, and is only open to shareholders. The stakes are high for Icahn, who needs a win. The Wall Street lion is facing an from a... + más
Illumina ordered by FTC to unwind $7b Grail deal from 2021 | The Boston Globe
CNBC USA Health March 21, 2023
In this articleCarl IcahnAdam Jeffery CNBC Biotech company pushed back Monday against Carl Icahn's proxy fight over the company's acquisition of cancer test developer Grail, saying the activist investor's board nominees do not add value. The San Diego-based DNA... + más
Carl Icahn claims Illumina directors got extra insurance to close 'disastrous' $7.1 billion Grail deal | CNBC
Icahn proposes three candidates for Illumina’s board — Here’s what could be next in the battle | CNBC
MarketWatch USA Business February 02, 2023
While Covid-19 assay sales are dropping, sales of the non-Covid tests that run on the Panther were up 24.5% in the first quarter of the company’s 2023 fiscal year, which ended at the end of December. That is good news for the company’s argument, , that the Panther machines... + más
How Ukrainian artists are grappling with war | The Boston Globe
Boom taps Kratos to power supersonic plane Overture, delays rollout | Fox Business
WPTV USA Business October 07, 2022
The products and services mentioned below were selected independent of sales and advertising. However, Don't Waste Your Money may receive a small commission from the purchase of any products or services through an affiliate link to the retailer's website.If you prefer... + más
Amazon announces Prime early access sale on Oct. 11-12 | WPTV
The Best Movies and TV Shows Coming to Netflix, HBO, Amazon Prime, and Hulu in October | Slate
About iurex | Privacy Policy | Disclaimer |